Profile data is unavailable for this security.
About the company
Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.
- Revenue in INR (TTM)2.09bn
- Net income in INR224.63m
- Incorporated1978
- Employees940.00
- LocationJagsonpal Pharmaceuticals LtdT 210J, ShahpurjatNEW DELHI 110049IndiaIND
- Phone+91 1 126494519
- Fax+91 1 126494708
- Websitehttps://www.jagsonpal.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wanbury Ltd | 5.76bn | 559.56m | 6.19bn | 1.58k | 11.07 | 22.17 | 8.98 | 1.08 | 17.09 | 17.09 | 175.71 | 8.53 | 1.78 | 10.43 | 7.27 | -- | 17.30 | 11.63 | 99.14 | -- | 47.43 | 43.79 | 9.72 | 7.62 | 0.5757 | 1.95 | 0.8065 | -- | 15.21 | 8.02 | 638.26 | -- | 29.87 | -- |
Nectar Lifesciences Ltd | 16.86bn | 49.95m | 6.40bn | 1.59k | 124.09 | 0.5986 | 9.74 | 0.3797 | 0.23 | 0.23 | 79.16 | 47.68 | 0.7697 | 1.74 | 5.12 | -- | 0.228 | -0.2956 | 0.3969 | -0.541 | 28.68 | 18.39 | 0.2963 | -0.4052 | 0.5907 | 1.06 | 0.3728 | -- | 10.63 | -9.54 | 120.65 | -36.29 | -5.06 | -- |
Albert David Ltd | 3.62bn | 754.20m | 6.85bn | 1.50k | 9.08 | 1.79 | 8.33 | 1.89 | 132.16 | 132.16 | 635.15 | 671.05 | 0.7868 | 2.58 | 11.23 | 2,421,254.00 | 16.37 | 10.00 | 20.85 | 13.15 | 65.13 | 59.85 | 20.81 | 11.87 | 3.29 | 124.70 | 0.0086 | 12.89 | 6.12 | 2.72 | 108.49 | 33.59 | 40.87 | 13.90 |
Sakar Healthcare Ltd | 1.53bn | 116.71m | 7.07bn | 297.00 | 58.33 | 2.69 | 23.78 | 4.61 | 5.57 | 5.57 | 73.21 | 120.61 | 0.423 | 3.88 | 7.13 | -- | 3.22 | 5.26 | 3.81 | 6.28 | 45.43 | 44.13 | 7.60 | 10.12 | 0.743 | 2.68 | 0.2322 | -- | 14.99 | 17.58 | -8.53 | 11.76 | 19.05 | -- |
IND Swift Laboratories Ltd | 12.81bn | 3.07bn | 7.71bn | 1.50k | 2.51 | 0.828 | 2.14 | 0.6021 | 51.99 | 51.99 | 216.90 | 157.64 | 0.857 | 3.45 | 3.80 | -- | 20.58 | 5.00 | 25.67 | 6.13 | 39.47 | 42.82 | 24.02 | 8.52 | 2.94 | 1.70 | 0.0175 | -- | 6.10 | 11.10 | 784.44 | 70.82 | 23.60 | -- |
Panacea Biotec Ltd | 5.59bn | -9.40m | 8.22bn | 1.09k | -- | 0.976 | 23.34 | 1.47 | -0.16 | -0.16 | 91.52 | 137.48 | 0.4452 | 1.21 | 9.52 | -- | -0.1194 | 10.26 | -0.1597 | 16.53 | 58.85 | 52.88 | -0.2683 | 24.87 | 0.9948 | -15.86 | 0.0244 | -- | 21.57 | 4.13 | 96.48 | -- | 74.65 | -- |
Jagsonpal Pharmaceuticals Ltd | 2.09bn | 224.63m | 9.14bn | 940.00 | 40.79 | 4.87 | 37.89 | 4.38 | 8.47 | 8.47 | 78.31 | 70.88 | 1.01 | 5.27 | 13.12 | -- | 10.90 | 10.95 | 12.30 | 13.29 | 55.00 | 58.17 | 10.76 | 9.21 | 9.63 | 26.29 | 0.0455 | 43.81 | -11.83 | 4.58 | -15.94 | 25.50 | -35.69 | 82.06 |
JG Chemicals Ltd | 6.68bn | 308.56m | 9.37bn | 112.00 | 28.01 | 2.35 | 25.57 | 1.40 | 8.54 | 8.54 | 185.73 | 101.67 | -- | -- | -- | -- | -- | -- | -- | -- | 14.64 | -- | 4.81 | -- | 8.57 | 45.21 | 0.0329 | -- | -14.90 | -- | -43.84 | -- | -- | -- |
Bajaj Healthcare Ltd | 4.73bn | -143.27m | 9.59bn | 1.06k | -- | 3.45 | 72.18 | 2.03 | -5.18 | -30.36 | 171.62 | 100.86 | 0.5681 | 1.44 | 2.32 | -- | -1.72 | 6.97 | -3.51 | 12.73 | 46.18 | 30.16 | -3.03 | 7.20 | 0.8096 | 1.64 | 0.5446 | 5.38 | -29.69 | 5.04 | -133.30 | -- | 15.08 | -- |
Remus Pharmaceuticals Ltd | 450.27m | 85.03m | 11.26bn | 38.00 | 119.61 | 43.35 | 125.40 | 25.01 | 15.98 | 15.98 | 90.25 | 44.09 | -- | -- | -- | 11,849,290.00 | -- | -- | -- | -- | 52.39 | -- | 18.88 | -- | 1.35 | -- | 0.2933 | -- | 82.17 | -- | 151.14 | -- | -- | -- |
Kopran Ltd | 6.15bn | 509.56m | 11.31bn | 394.00 | 22.34 | 2.30 | 17.72 | 1.84 | 10.50 | 10.50 | 126.95 | 101.90 | 0.8824 | 2.99 | 3.28 | -- | 7.32 | 8.47 | 10.22 | 12.23 | 34.60 | 34.18 | 8.29 | 8.89 | 1.44 | 43.23 | 0.168 | 25.41 | 11.54 | 11.42 | 87.11 | 16.23 | 12.53 | -- |
Bliss GVS Pharma Ltd | 7.70bn | 754.54m | 11.76bn | 831.00 | 15.82 | 1.21 | 10.89 | 1.53 | 7.08 | 7.08 | 72.80 | 92.39 | 0.6498 | 3.19 | 1.95 | 9,268,892.00 | 6.88 | 6.46 | 8.37 | 8.22 | 50.39 | 43.91 | 10.59 | 9.92 | 4.22 | -- | 0.0905 | 7.92 | 2.48 | -3.03 | 6.49 | -9.42 | -8.33 | -12.94 |
Data as of Jul 24 2024. Currency figures normalised to Jagsonpal Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
0.00%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Motilal Oswal Asset Management Co. Ltd.as of 30 Jun 2024 | 110.00 | 0.00% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.